Commentary on: Do proton pump inhibitors prevent Barrett's esophagus progression to high-grade dysplasia and esophageal adenocarcinoma? An updated meta-analysis.

Li, Jia; Fan, Yuwei

Li, Jia; Fan, Yuwei.

Affiliation

Li J; Department of Oncology, The First Affiliated Hospital of Kangda College of Nanjing Medical University, Lianyungang, 222061, Jiangsu Province, China.
Fan Y; Department of Oncology, The First Affiliated Hospital of Kangda College of Nanjing Medical University, Lianyungang, 222061, Jiangsu Province, China. liu029030yu@163.com.

J Cancer Res Clin Oncol ; 147(9): 2801-2802, 2021 09.

Article in En | MEDLINE | ID: mdl-34086128

Subject(s)

Adenocarcinoma; Barrett Esophagus; Esophageal Neoplasms; Adenocarcinoma/prevention & control; Barrett Esophagus/drug therapy; Barrett Esophagus/prevention & control; Esophageal Neoplasms/prevention & control; Humans; Proton Pump Inhibitors/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 Database: MEDLINE Main subject: Barrett Esophagus / Esophageal Neoplasms / Adenocarcinoma Type of study: Systematic_reviews Limits: Humans Language: En Journal: J Cancer Res Clin Oncol Year: 2021 Document type: Article

Fulltext

XML

PubMed Links

Search on Google